Clinical Trial Update: A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This is a Phase II study of radiation therapy combined with paclitaxel poliglumex and carboplatin for stage III non-small cell lung cancer; the trial was termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Paclitaxel poliglumex (paclitaxel poliglumex)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: TERMINATED | Results posted: 2015-05-27